Product Code: ETC417460 | Publication Date: Oct 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Polymyxin B Sulfate is used to treat serious bacterial infections. In Bahrain, it is prescribed for resistant infections, particularly in hospitals. Its market is small, but demand is stable due to ongoing challenges with antibiotic resistance.
The Polymyxin B sulfate market in Bahrain is small but crucial for treating multi-drug-resistant infections. With growing concerns over antibiotic resistance, this last-resort antibiotic is receiving heightened attention in clinical settings. Hospitals and specialty pharmacies are the key buyers, and stringent storage and usage protocols are followed. Government procurement programs are helping maintain adequate supply and affordability. Surveillance of resistant pathogens is also driving informed prescribing of such potent antibiotics.
The polymyxin B sulfate market in Bahrain is facing challenges due to concerns over antimicrobial resistance and the drugs limited therapeutic window. This antibiotic is often considered a last-resort treatment for multi-drug-resistant infections, which limits its usage to critical care settings with close medical supervision. Most healthcare facilities in Bahrain prioritize newer, less toxic alternatives, leading to inconsistent demand for polymyxin B. Its nephrotoxic and neurotoxic side effects require careful dosage and patient monitoring, which may not be feasible in all hospitals. Additionally, importing this specialty antibiotic requires specific storage conditions and regulatory approvals, causing delays and increasing costs. Local distributors are reluctant to stock large quantities due to its short shelf life and restricted indications. As a result, despite its medical importance, polymyxin B sulfate remains a niche product with limited commercial prospects in Bahrain.
Polymyxin B sulfate, an antibiotic used to treat severe bacterial infections, presents investment opportunities in Bahrains expanding healthcare and pharmaceutical sectors. As the country works toward enhancing its healthcare capabilities and providing more advanced treatment options for infectious diseases, there will be a growing demand for antibiotics like polymyxin B sulfate. Bahrain`s increasing focus on modernizing healthcare infrastructure, particularly in its hospitals and healthcare institutions, will drive the need for such medical treatments. Investors can explore opportunities for local manufacturing or distribution of polymyxin B sulfate to ensure a steady supply of critical antibiotics. With the rise of antibiotic-resistant bacteria, there is an increased need for effective antimicrobial therapies, making the demand for polymyxin B sulfate more prominent. Regulatory compliance, particularly in the pharmaceutical sector, will be a critical consideration for businesses entering this market to ensure the safe and responsible production of the drug.
Polymyxin B Sulfate, a critical antibiotic used in treating drug-resistant infections, is regulated in Bahrain as part of the essential medicines list under the NHRA. Only licensed medical facilities and professionals can prescribe and dispense this drug, and its importation must be backed by proof of clinical necessity and source traceability. The Ministry of Health enforces batch testing and documentation of product efficacy and safety, especially for injectable forms. Hospitals are mandated to report usage statistics to ensure responsible antibiotic stewardship and to monitor antimicrobial resistance patterns. The government promotes hospital-level infection control protocols and prescriber training as part of its healthcare quality strategy. Procurement processes prioritize WHO-prequalified suppliers. Bahrains oversight reflects a focused commitment to combating antibiotic resistance while ensuring availability of life-saving drugs.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Polymyxin B Sulfate Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Polymyxin B Sulfate Market Revenues & Volume, 2021 & 2031F |
3.3 Bahrain Polymyxin B Sulfate Market - Industry Life Cycle |
3.4 Bahrain Polymyxin B Sulfate Market - Porter's Five Forces |
3.5 Bahrain Polymyxin B Sulfate Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Bahrain Polymyxin B Sulfate Market Revenues & Volume Share, By Applications, 2021 & 2031F |
4 Bahrain Polymyxin B Sulfate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Bahrain |
4.2.2 Rising awareness about the effectiveness of polymyxin B sulfate in treating multi-drug resistant infections |
4.2.3 Growth in healthcare infrastructure and investment in pharmaceuticals sector in Bahrain |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of polymyxin B sulfate products |
4.3.2 Limited availability of skilled healthcare professionals for proper administration and monitoring of polymyxin B sulfate treatments |
5 Bahrain Polymyxin B Sulfate Market Trends |
6 Bahrain Polymyxin B Sulfate Market, By Types |
6.1 Bahrain Polymyxin B Sulfate Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Types, 2021 - 2031F |
6.1.3 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Injections, 2021 - 2031F |
6.2 Bahrain Polymyxin B Sulfate Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
6.2.4 Bahrain Polymyxin B Sulfate Market Revenues & Volume, By Others, 2021 - 2031F |
7 Bahrain Polymyxin B Sulfate Market Import-Export Trade Statistics |
7.1 Bahrain Polymyxin B Sulfate Market Export to Major Countries |
7.2 Bahrain Polymyxin B Sulfate Market Imports from Major Countries |
8 Bahrain Polymyxin B Sulfate Market Key Performance Indicators |
8.1 Number of new cases of multi-drug resistant infections in Bahrain |
8.2 Investment in research and development of polymyxin B sulfate formulations by pharmaceutical companies operating in Bahrain |
8.3 Number of healthcare facilities offering polymyxin B sulfate treatments in Bahrain |
9 Bahrain Polymyxin B Sulfate Market - Opportunity Assessment |
9.1 Bahrain Polymyxin B Sulfate Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Bahrain Polymyxin B Sulfate Market Opportunity Assessment, By Applications, 2021 & 2031F |
10 Bahrain Polymyxin B Sulfate Market - Competitive Landscape |
10.1 Bahrain Polymyxin B Sulfate Market Revenue Share, By Companies, 2024 |
10.2 Bahrain Polymyxin B Sulfate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |